billHR5894Event Wednesday, November 19, 2025Analyzed

RESTRAIN Act

Neutral

Summary

The RESTRAIN Act (HR5894) is a procedural bill that codifies the existing U.S. moratorium on explosive nuclear weapons testing. It carries zero funding, no new appropriations, and no operational changes for defense contractors. Market impact is neutral across all affected tickers.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR5894 codifies an existing moratorium already in practice since 1992 — no policy change.
  • 2.Zero funding, zero appropriations, zero operational impact on defense contractors.
  • 3.The bill is stalled in committee with no near-term path to passage.
  • 4.Defense stock recent declines (15%+ over 30 days) are unrelated to this procedural bill.

Market Implications

No market implications. The RESTRAIN Act is a purely symbolic codification of existing U.S. policy. Defense contractors — including $LMT at $509.75, $NOC at $576.37, $GD at $342.26, and $RTX at $174.87 — see zero revenue or operational changes from this bill. Market movement in these names over the assessment period has been driven by unrelated macroeconomic factors: $LMT has fallen 15.66% in 30 days, $NOC 15.52%, $RTX 9.35%, while $GD fell only 0.28% (partially recovering from a late-April dip). These trends are disconnected from this legislative action.

Full Analysis

  1. WHAT HAPPENED: On October 31, 2025, Rep. Dina Titus (D-NV-1) introduced HR5894, the RESTRAIN Act, in the House. The bill was referred to the House Committee on Armed Services. As of the latest action on November 19, 2025, the sponsor delivered introductory remarks. The bill has 26 cosponsors and remains in committee. No further legislative steps (hearings, markups, floor votes) have occurred.

  2. THE MONEY TRAIL: Zero. The bill authorizes no funding, appropriates no money, and makes no changes to existing NNSA or Department of Defense budget authority. It simply converts an existing policy (the U.S. moratorium on explosive nuclear testing, in place since 1992) into statutory language. Subcritical nuclear tests are explicitly exempted under Section 2(d)(2), preserving existing stockpile stewardship and life-extension programs.

  3. STRUCTURAL IMPACT: The bill is neutral for all defense contractors. The four major defense primes—Lockheed Martin ($LMT), Northrop Grumman ($NOC), General Dynamics ($GD), and RTX ($RTX)—have no revenue exposure tied to explosive nuclear weapons testing. Their nuclear-related programs (e.g., Trident missile systems, Sentinel ICBM, nuclear submarines, nuclear C2 systems) rely on design, simulation, subcritical testing, and sustainment contract vehicles that are unaffected. No contractor gains or loses a competitive advantage.

  4. REAL MARKET DATA CONTEXT: Over the past 30 days, major defense stocks have experienced significant selloffs unrelated to this bill. $LMT is down 15.66% to $509.75, $NOC down 15.52% to $576.37, $GD down 0.28% to $342.26, and $RTX down 9.35% to $174.87. These moves are driven by broader market dynamics, not the RESTRAIN Act. The bill's introduction on 2025-10-31 had no measurable effect on defense stock prices in the following sessions.

  5. TIMELINE: The bill is stalled in committee with no scheduled markup. With the current Congress (119th, 2025-2027) now past the one-year mark, bills without bipartisan momentum are unlikely to advance unless pulled for floor consideration. The bill's sponsor is a junior Democratic member from Nevada, and given the partisan makeup, passage is improbable in this session. No companion bill exists in the Senate.

Intelligence Surface

Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures

Strong

Multiple independent sources confirm this signal’s market thesis

Confirmed by:
$$LMT● Neutral

What the bill does

Statutory prohibition on explosive nuclear weapons testing, codifying existing U.S. moratorium; no change to procurement, development, or test infrastructure programs.

Who must act

U.S. Department of Energy / National Nuclear Security Administration (NNSA)

What happens

No explosive testing may be conducted; subcritical tests remain permitted. Current NNSA stockpile stewardship programs (e.g., enhanced surety, life extension) are unaffected.

Stock impact

Lockheed Martin's nuclear-related revenue (e.g., nuclear command & control, trident missile system support) relies on ongoing life-extension and sustainment contracts, not explosive testing. No impact on revenue streams.

$$NOC● Neutral

What the bill does

Statutory prohibition on explosive nuclear weapons testing, codifying existing U.S. moratorium; no change to procurement, development, or test infrastructure programs.

Who must act

U.S. Department of Energy / National Nuclear Security Administration (NNSA)

What happens

No explosive testing may be conducted; subcritical tests remain permitted. Current NNSA stockpile stewardship programs are unaffected.

Stock impact

Northrop Grumman's nuclear-related work is centered on the Sentinel ICBM program (GBSD) and strategic deterrent systems. These programs depend on design and certification, not explosive testing. No revenue impact.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

presidential_memorandumJun 12, 2026

National Security Presidential Memorandum/NSPM-12

This memorandum rescinds previous national security directives and re-establishes the Committee on National Security Systems (CNSS) to enforce baseline cybersecurity standards across all National Security Systems (NSS) operated by the Department of War, Intelligence Community, and Federal Civilian Executive Branch agencies. It creates binding directives and complementary standards that must meet or exceed NIST guidelines, empowers the NSA Director as the National Manager to issue emergency directives and cryptography requirements, and holds agency heads accountable through government-wide oversight.

presidential_memorandumJun 5, 2026

National Security Presidential Memorandum/NSPM-11

This memorandum directs the national security enterprise (including the Department of War, intelligence agencies, and others) to accelerate the adoption, adaptation, and assurance of AI technologies for military and intelligence missions. It mandates updates to DOD Directive 3000.09 on autonomous weapons within 90 days, requires termination of contracts with companies that repeatedly violate policy (e.g., by enabling adversary control or embedding bias), and emphasizes supply chain resilience and multi-vendor sourcing to avoid single-vendor dependencies.

Exec OrderJun 3, 2026

Implementing Schedule Policy/Career in the Excepted Service

This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →